Affiliation: University of Oxford
- Cannabis and the brainLeslie Iversen
Department of Pharmacology, University of Oxford, Oxford, UK
Brain 126:1252-70. 2003..Medicines based on drugs that enhance the function of endocannabinoids may offer novel therapeutic approaches in the future...
- GABA pharmacology--what prospects for the future?Leslie Iversen
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX13QT, UK
Biochem Pharmacol 68:1537-40. 2004..Gaboxadol (THIP) is an example of a novel hypnotic that acts on GABA-A receptors by a non-benzodiazepine mechanism. Exploiting neurosteroid interactions with GABAergic mechanisms also holds much future promise...
- Neurotransmitter transporters and their impact on the development of psychopharmacologyLeslie Iversen
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT
Br J Pharmacol 147:S82-8. 2006..So far, only one new amino-acid transporter-related drug has become available: the GABA uptake inhibitor tiagabine as a novel antiepileptic agent...
- Cannabinoids: a real prospect for pain relief?Leslie Iversen
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK
Curr Opin Pharmacol 2:50-5. 2002..Development of novel cannabinoid agonists and cannabinoid preparations that are antinociceptive has important implications for the therapeutic use of this class of drugs...
- Long-term effects of exposure to cannabisLeslie Iversen
University of Oxford, Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, UK
Curr Opin Pharmacol 5:69-72. 2005..Overall, by comparison with other drugs used mainly for 'recreational' purposes, cannabis could be rated to be a relatively safe drug...